# Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C

> **NCT00148863** · PHASE2 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 65 (—)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Peg-interferon alpha 2a (drug)
- **DRUG:** Ribavirin (drug)
- **DRUG:** Interferon gamma (drug)

## Key facts

- **NCT ID:** NCT00148863
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 65 (—)
- **Last updated:** 2007-08-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148863, "Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00148863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*